Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ashaimaa Y. Moussa, Hagar A. Sobhy, Omayma A. Eldahshan & Abdel Nasser B. Singab. (2021) Caspicaiene: a new kaurene diterpene with anti-tubercular activity from an Aspergillus endophytic isolate in Gleditsia caspia desf. Natural Product Research 35:24, pages 5653-5664.
Read now
Read now
Vanja P. Ničković, Zorica N. Vujnović-Živković, Rada Trajković, Dane Krtinić, Lidija Ristić, Milan Radović, Zorica Ćirić, Dušan Sokolović & Aleksandar M. Veselinović. (2019) In silico studies and the design of novel agents for the treatment of systemic tuberculosis. Journal of Biomolecular Structure and Dynamics 37:12, pages 3198-3205.
Read now
Read now
Jan Zitko & Martin Doležal. (2016) Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 – 2015). Expert Opinion on Therapeutic Patents 26:9, pages 1079-1094.
Read now
Read now
Articles from other publishers (23)
Qianqian Zhang, Jianting Han, Yongchang Zhu, Fansen Yu, Xiaopeng Hu, Henry H. Y. Tong & Huanxiang Liu. (2023) Discovery of novel and potent InhA direct inhibitors by ensemble docking-based virtual screening and biological assays. Journal of Computer-Aided Molecular Design 37:12, pages 695-706.
Crossref
Crossref
Mayursinh Zala, Jwalant J. Vora & Vijay M. Khedkar. (2023) Synthesis, Characterization, Antitubercular Activity, and Molecular Docking Studies of Pyrazolylpyrazoline-Clubbed Triazole and Tetrazole Hybrids. ACS Omega 8:23, pages 20262-20271.
Crossref
Crossref
Dian Ayu Eka Pitaloka, Arfan Arfan, Nayla Majeda Alfarafisa, Lidya Chaidir & Unang Supratman. (2023) Discovery of potent triterpenoid and limonoid compounds targeting Mycobacterium tuberculosis enoyl acyl carrier protein reductase (InhA): An in silico investigation. Informatics in Medicine Unlocked 40, pages 101299.
Crossref
Crossref
Jhesua Valencia, Vivian Rubio, Gloria Puerto, Luisa Vasquez, Anthony Bernal, José R. Mora, Sebastian A. Cuesta, José Luis Paz, Braulio Insuasty, Rodrigo Abonia, Jairo Quiroga, Alberto Insuasty, Andres Coneo, Oscar Vidal, Edgar Márquez & Daniel Insuasty. (2022) QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-Based Thiosemicarbazones against Mycobacterium tuberculosis. Antibiotics 12:1, pages 61.
Crossref
Crossref
Pratibha D. Gupta, Kalpana N. Tilekar, Neha M. Upadhyay & Ramaa C.S. (2022) Recent Discoveries of Nitrogen-Containing Heterocyclic Compounds as
InhA Inhibitors against Mycobacterium tuberculosis: An Overview. Infectious Disorders - Drug Targets 22:8.
Crossref
Crossref
S H Sukanya, Talavara Venkatesh, S J Aditya Rao & Anup Pandith. (2022) An efficient p‐TSA catalyzed synthesis of some new substituted‐(5‐hydroxy‐3‐phenylisoxazol‐4‐yl)‐1,3‐dimethyl‐1H‐chromeno[2,3‐d]pyrimidine‐2,4(3H,5H)‐dione/3,3‐dimethyl‐2H‐xanthen‐1(9H)‐one scaffolds and evaluation of their pharmacological and computational investigations. Journal of Molecular Structure 1267, pages 133587.
Crossref
Crossref
Chayanin Hanwarinroj, Nareudon Phusi, Bundit Kamsri, Pharit Kamsri, Auradee Punkvang, Sombat Ketrat, Patchreenart Saparpakorn, Supa Hannongbua, Khomson Suttisintong, Prasat Kittakoop, James Spencer, Adrian J Mulholland & Pornpan Pungpo. (2022)
Discovery of novel and potent InhA inhibitors by an
in silico
screening and pharmacokinetic prediction
. Future Medicinal Chemistry 14:10, pages 717-729.
Crossref
Crossref
Magaly Girão Albuquerque, Raoni Schroeder B. Gonçalves, Camilo Henrique da Silva Lima, Fernanda Lima de Azevedo Maia, Sérgio de Paula Machado, Laudicéa do Nascimento Oliveira, Talis Uelisson da Silva, James L. Wardell & Solange M.S.V. Wardell. (2021) Crystal structures, DFT calculations and Hirshfeld surface analysis of two (E)-3-(aryl)-1-(naphthalen-1-yl)prop-2-en-1-one chalcone derivatives, potential Mycobacterium tuberculosis Enoyl ACP reductase (InhA) inhibitors and optical materials: conformational differences within the prop-2-en-1-one unit. Journal of Molecular Structure 1246, pages 131091.
Crossref
Crossref
Anuchit Phanumartwiwath, Chatchai Kesornpun, Sanya Sureram, Poonpilas Hongmanee, Pornpan Pungpo, Pharit Kamsri, Auradee Punkvang, Chatchakorn Eurtivong, Prasat Kittakoop & Somsak Ruchirawat. (2021)
Antitubercular and antibacterial activities of isoxazolines derived from natural products: Isoxazolines as inhibitors of
Mycobacterium tuberculosis
InhA
. Journal of Chemical Research 45:11-12, pages 1003-1015.
Crossref
Crossref
Mayuri S. Prasad, Ritesh P. Bhole, Pramod B. Khedekar & Rupesh V. Chikhale. (2021) Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery. Bioorganic Chemistry 115, pages 105242.
Crossref
Crossref
Dalin Rifat, Liang Chen, Barry N. Kreiswirth & Eric L. Nuermberger. (2021)
Genome-Wide Essentiality Analysis of
Mycobacterium abscessus
by Saturated Transposon Mutagenesis and Deep Sequencing
. mBio 12:3.
Crossref
Crossref
Moagi Shaku, Christopher Ealand & Bavesh D. Kana. (2020) Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Maurício Boff de Ávila, Gabriela Bitencourt-Ferreira & Walter Filgueira de Azevedo. (2020) Structural Basis for Inhibition of Enoyl-[Acyl Carrier Protein] Reductase (InhA) from Mycobacterium tuberculosis. Current Medicinal Chemistry 27:5, pages 745-759.
Crossref
Crossref
Pharit Kamsri, Chayanin Hanwarinroj, Naruedon Phusi, Thimpika Pornprom, Kampanart Chayajarus, Auradee Punkvang, Nitima Suttipanta, Potjanee Srimanote, Khomson Suttisintong, Chomphunuch Songsiriritthigul, Patchreenart Saparpakorn, Supa Hannongbua, Siriluk Rattanabunyong, Supaporn Seetaha, Kiattawee Choowongkomon, Sanya Sureram, Prasat Kittakoop, Poonpilas Hongmanee, Pitak Santanirand, Zhaoqiang Chen, Weiliang Zhu, Rosemary A. Blood, Yuiko Takebayashi, Philip Hinchliffe, Adrian J. Mulholland, James Spencer & Pornpan Pungpo. (2019) Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography. Journal of Chemical Information and Modeling 60:1, pages 226-234.
Crossref
Crossref
E. V. Verbitskiy, G. L. Rusinov, V. N. Charushin & O. N. Chupakhin. (2020) Development of new antituberculosis drugs among of 1,3- and 1,4-diazines. Highlights and perspectives. Russian Chemical Bulletin 68:12, pages 2172-2189.
Crossref
Crossref
Avinash Kumar, Rajappan Revathi, Dharmarajan Sriram, Francesca Curreli, Asim K. Debnath, K. Sreedhara Pai & Suvarna G. Kini. (2019) Targeting HIV‐TB coinfection by developing novel piperidin‐4‐substituted imines: Design, synthesis, in vitro and in silico studies. Archiv der Pharmazie 352:6.
Crossref
Crossref
Sushma J. Takate, Abhijit D. Shinde, Bhausaheb K. Karale, Hemant Akolkar, Laxman Nawale, Dhiman Sarkar & Pravin C. Mhaske. (2019) Thiazolyl-pyrazole derivatives as potential antimycobacterial agents. Bioorganic & Medicinal Chemistry Letters 29:10, pages 1199-1202.
Crossref
Crossref
Veronika Šlachtová & Lucie Brulíková. (2018) Benzoxazole Derivatives as Promising Antitubercular Agents. ChemistrySelect 3:17, pages 4653-4662.
Crossref
Crossref
Rudolf Vosátka, Martin Krátký & Jarmila Vinšová. (2018) Triclosan and its derivatives as antimycobacterial active agents. European Journal of Pharmaceutical Sciences 114, pages 318-331.
Crossref
Crossref
Shargina Beegum, Y. Sheena Mary, Hema Tresa Varghese, C. Yohannan Panicker, Stevan Armaković, Sanja J. Armaković, Jan Zitko, Martin Dolezal & C. Van Alsenoy. (2017) Vibrational spectroscopic analysis of cyanopyrazine-2-carboxamide derivatives and investigation of their reactive properties by DFT calculations and molecular dynamics simulations. Journal of Molecular Structure 1131, pages 1-15.
Crossref
Crossref
Kaja Rožman, Izidor Sosič, Raquel Fernandez, Robert J. Young, Alfonso Mendoza, Stanislav Gobec & Lourdes Encinas. (2017) A new ‘golden age’ for the antitubercular target InhA. Drug Discovery Today 22:3, pages 492-502.
Crossref
Crossref
Diego G. Ghiano, Agustina de la Iglesia, Nina Liu, Peter J. Tonge, Héctor R. Morbidoni & Guillermo R. Labadie. (2017) Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives. European Journal of Medicinal Chemistry 125, pages 842-852.
Crossref
Crossref
Jozef Stec & Ehab A Abourashed. (2015) Recently disclosed chemical entities as potential candidates for management of tuberculosis. Pharmaceutical Patent Analyst 4:4, pages 317-347.
Crossref
Crossref